CLLS
Cellectis (CLLS)
$80
About Cellectis (CLLS)
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Details
Daily high
$2.97
Daily low
$2.80
Price at open
$2.80
52 Week High
$5.48
52 Week Low
$2.00
Market cap
194.6M
Dividend yield
0.00%
Volume
20,697
Avg. volume
21,055
P/E ratio
-3.99
Cellectis News
Details
Daily high
$2.97
Daily low
$2.80
Price at open
$2.80
52 Week High
$5.48
52 Week Low
$2.00
Market cap
194.6M
Dividend yield
0.00%
Volume
20,697
Avg. volume
21,055
P/E ratio
-3.99